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Mutations within the gene encoding the anchoring 
fibril protein type VII collagen (COL7Al) have re-
cently been established as the pathogenetic basis for 
the inherited blistering skin disorder, dystrophic epi-
dermolysis bullosa. We report a patient with a mod-
erately severe phenotype of recessive dystrophic epi-
dermolysis bullosa, in whom COL7Al mutations have 
been identified on both alleles. The patient is a 
5-y-old Japanese male of nonconsanguineous par-
ents, with clinical features including generalized 
trauma-induced blistering since birth, complete loss 
of nails, and partial fusion of the fingers and toes. 
Immunofluorescence microscopy examination of the 
dermal-epidermal junction in the patient's skin re-
vealed near-normal intensity staining with an anti-
type VII collagen antibody (LH7:2). Transmission 
electron microscopy showed a reduced number of 
D ystrophic epidermolysis bullosa (DEB) is a hetero-geneous group of mechanobullous disorders which are inhe rited by autosoma l dominant or autosomal recessive transmission [1]. Linkage to the type VII collagen gene (COL7 A1) has been demonstrated in 
both dominant and recessive kindreds [2-5] , and a number of 
pathogenetic mutations within COL 7 A 1 have been disclosed in 
diJferent DEB phenotypes [6] . Typ e VII collagen is synthesized by 
basal keratinocytes and by dermal fibro blasts, and is the major, if 
not the exclusive, component of anchoring fibrils at the dermal-
epidermal junctio n. T hese attachment structures are ultrastructur-
ally abnormal in DEB [7,8] . 
Tn this study, w e examined skin fi'om a Japanese patient with a 
moderately severe form of r ecessive DEB by immunofluores cence 
microscopy for type VlI collagen antibody staining and by tmns-
mission electron microscopy to assess anchoring fibL;1 morphology. 
Genom ic DNA fi'om the nuclear famil y was used to search for 
mutations by polyme rase chain reaction (PCR) amplifi cation of 
COL7Al, followed by he teroduple x analysis and nucleotide se-
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thin. poorly-formed anchoring fibrils. PCR amplifi-
cation of genomic DNA, followed by heteroduplex 
analysis, and nucleotide sequencing demonstrated 
that the patient was a compound heterozygote for a 
nonsense mutation (E2858X) within the NC-2 domain 
of type VII collagen and a missense mutation 
(G2576R) within the type VII collagen triple helix. 
Both mutations were verified by restriction endonu-
clease digestion. Information about these mutations 
advances our understanding of genotype-phenotype 
correlations in dystrophic epidermolysis bullosa, and 
further delineates the mechanisms involved in der-
mal-epidermal dysadhesion. Key 1V01'ds: tl'pe VII colla-
gell mll.tatiollslmo(ecu[a.l· gelletics of EBI",,,tatiotl detection ill 
gellOderlllatosesli1lllel,itable blistel71tg diseases. ] Invest Del'-
malol 106:119-124, 1996 
quencin g. T he seque nce alterations were veri.fied by restn ctJon 
endonuclease digestion . T he aims of the study were to de fine the 
m o lecular basis of th e )'ecessive DEB ill this patient and to 
contribute to the expanding knowledge of genotype-phen otype 
corre lations in this hereditary skin disease. 
MATER1 ALS AND M ETHODS 
Patient T he patient is a 5-y-o ld Ja panese male. and is the o nl y child of 
nOllconsanguineous parents. T here is no famil y hi stol'y of blistering disor-
ders o r other skin di seases . Erosions and bli sters had beell present 0 11 acra l 
skin at birth. Gene ralized trallma-induced bli sterin g with subscquellt sca r-
rin g h"d developed thereafter, but Ilotably there h ad only been partial fusio n 
of the fin gers and toes. T hus, the cl inica l features ill thi s patient "re 
consistent with a moderatel y severe pheno type bu t arc less severe than the 
Illutil"ting, Hallopcau-Siem ens subtype of recessive DEB 111 . 130th parents 
arc clinica lly normal. 
Samples Skin biopsy was ta ke" fro m the patient under local anesthetic 
from the edge of a fresh blister and di vided fo r immunoAuoresccnce and 
electro n Inicroscopy. Skin biopsies ,"vcrc una va ilable frorn the parents . 
Genomic DNA was extracted fro m peripher<ll blood lymphocytes of the 
patie llt and b o th parents by standard meth ods [91. 
IITI1TIUl1ofluorcSCCllce Inl11'lUno flu o rcscencc studi es 'were pcrfornlcd on 
6-fLlI1 cryostat sec ti ons. as repo rted previo usly 11 01. Primary antibodies 
cOlISisted of LH7 :2 (kindly provided b y Professor l.M . Leigh. The Royal 
Lo ndon Hospital) . G I3 .3 (Sera-Lab. C ambridge , UK). " nd an ti-type rv 
collagen (Dako, G lostrup. Denmark.) . LH7:2 labels an ep itope w ithin the 
NC-1 region of type VII co llagen [11 -13], GB3 recognizes a confonna-
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Figure 1. Clinical features of the 5-y-oldJapanese patient with a moderately severe clinical va.riant o f recessive DEB. n) Scarring of the fltlgers 
with partial fus ion and mild f.xed-flexion deformity. I}) Similar changes are present o n the toes, ill addition to com ple te loss of nails. c) Moderate scarring, 
blister formatio n , and slow-healing erosions are present o n the lower limbs. eI) Som e scarring in and around the mo uth is present, with dystrophic dental 
abno rmali ties, but there is no significant microstomia . c) Numero us mili a are present. here illustrated at a site of previous blisterill g 0 11 the lower abdomen. 
tional epitope on the anchoring filament compo nent lamin ill 5 [1 4 -1 6] , and 
type IV coLl agen is a ubiqui tous component of the lamina densa [17] . T hese 
antibodies we re diluted 1:2, 1:50, and 1:1000, respectively, in phosphate-
buffered sa line/bovine serum albumin. Labeling was visuali zed using Auo-
rescein-conjugated rabbi t anti-mouse IgG an tibodies (Dako) dilu ted 1. :50 in 
phosphate-buffe red saline/bovine serum albumin . Sections were examined 
under a standard O lympus microscope equipped for epiAuo rescence. Fo r 
contro l purposes, S;Ul1p) cs fr0 l11 nOrlnal human sk.in and froll1 a patient with 
the severe, mutilating, HaIJopea u-Siemens form of recessive DEB were 
examined . Negative contro l incubations with no rmal mouse serum were 
also performed. 
Electron Microscopy Electron microscopy was performed as descri bed 
elsewhere [1 8]. BrieAy. specimens were fixed in 2')1. glu taraldehyde and 
osmium tetroxide . and then embedded in epoxy resin. U ltrathin sections. 
sta ined w ith uran yl acetate and lead citrate, were examined in a J EOl 
transmiss ion electron microscope. Skin specimens from an unaffected 
individua l, and from a patient with H allopeau-Siemens recessive DED were 
used as con tro ls . 
PCR Amplification and Hcteroduplex Analysis Genomic D N A was 
used as a template for amplificatio n of geno mic sequences ofCO L7 A 1. Pairs 
of o ligon ucleotide p"imers spanning all 11 8 exons of the gene [19] were 
synthes ized on the basis of intronic sequences to generate PC R. products 
(GcnDank no. l 23982). Specificall y, to amp li fy exons 11 6 and ·103/104 (see 
results), the fo llowing primers were used. For cxon ·116, the upstream 
primer was 5' - ACAGTGGAAATCAGTGCTGC-3' (nucleotides 33698-
33717) and the downstream primer w as 5 ' -A GGGTTTGTGGGAATCA-
GAG-3' (nucleotides 33972-3 3953). For the PCR product spanning exons 
103/104, the upstream primer was 5 ' - CGGGCT CGTTGTATT CTAAG-3' 
(nucleotides 30049-30068) and the downstream primer was 5'-CAAAAGC-
TACCACACTGGTG-3 ' (nucleotides 30561-30542) . For pC R amplification, 
approx imately 250 ng of genomic DNA was used as the templa te in 3n 
ampli fication bulfer containing 20 pmol of each primer, 1.5 mM MgCI2 , 20 
JLm ol of each nucleotide, and 2.5 U of Taq polymerase (Perkill Elmer Ccms, 
San Francisco, CAl in a tota l volume of 50 JL I. T he amplifica ti on conditions for 
both sets of primers were 94°C for 5 min ; fo llowed by 40 cycles of 94 °C for 45 
sec, 55°C for 45 sec, and 72°C for 45 sec in an OmniGene thermal cycler 
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(Marsh Scientific Inc., Rochester, NY). Aliquots of 5 ILl of the peR products 
were analyzed on 2"/r, agarose gel electrophoresis, and 3-10 J.LI of the smnple 
was prepared fo r hcteroduplex analysis according to the mm1Ufacture r's rec-
ommendations (MDE, JT Daker Inc., Phillipsburg. NJ, USA). Stain.ing with 
ethidium bromide was used to visualize the heteroduplexes. Samples COlmtin-
ing heteroduplcxes were subjected to direct sequencing by an ABI automated 
sequencer. 
Verification of the Mutations T he mutations detected in the pe R 
products (see ResHlts) were verifIed .in genomic DNA. T he eXOI1 11 6 
mutation resul ted in the creation of a novel restriction site for the 
endonuclease Bfn I. T he cxon 103 mutation resulted in the loss of a Mspl 
restriction site. T hc peR products spann.ing these exons were digested with 
the corresponding cnzymes according to the manuf.1Cturer's instructions 
(New England Biolabs, Beverly, MA) . 
RESULTS 
Diagnostic Features Representative clinical features of the 
pa tient are sh own in Fig 1. T hese include partial fusion of the 
fingers and toes (Fig la,"), w ith complete loss of nails (Fig lIJ) . 
Moderately severe scarrin g and blistering is present over elbows 
and knees (Fig lc) , along with som e dental caries and buccal 
scarrin g (Fig ld), and widespread milia (Fig le). These features are 
con sistent with a moderately scvere form of recessive DEB. 
Labeling of the dermal-epidermal junctio n in the patien t's ski.n 
with the anti-type VII coUagen antibody LH7:2 (Fig 2a) revea led 
normal or near-norma] intensity staining, compared with norma] 
control ski.n (Fig 2") . In contrast, labe ling with this antibody in the 
HaUopeau-Siemens RDEB patient skin sh owed a complete absence 
of staining at thc dermal-cpidermal junction. Labeling with GB3 
and an ti-type IV collagen antibod ies gave bright, linear basem ent 
membrane zon e flu o rescence in all sampl es . 
Low magnifi cation electron microscopic examinati on of the 
patient's skin (Fig 3a) showed blister fo rmation occurring beneath 
the lamina densa w ithin the superficial papillary dermis. Hjgber 
magnification (Fig 3b) revealed substantially reduced numbers o f 
anchoring fibrils co mpared w ith the con tro l sample . Although 
occasion al an ch o ring fibrils had a fa n-shaped appearance, with 
insertion into the lamina den sa and central cross-banding, most of 
the sublamina den sa fibt;Uar structures had on ly a wisp-like mor-
phology. Othcr compone nts of the d ermal-epidennal junction, 
including he midesl1losom es and an ch oring filaments, all showed no 
gross abnormalities. In the control Hallopeau-Siemens patient 
sample, no anchoring fibril o r anch o ring fibril-like structures were 
seen. 
Mutation Detection 
IdeHl.ificalio ll oj a Malemal NO lIsclIse Mlltaliol/: Hetcroduplex analysis 
of the PC R products spann.ing exon 116 (Fig 4A) revealed 
heteroduplex bands in tbe patie nt and m aternal sampl es, but only a 
homoduplex in the paternal sample. Automated sequen cing of the 
PCR product (Fig 4B) disclosed a G- to-T transversio n at nucle-
otide positio n 33810. This changes a g lu tamic acid residue (,GAG) 
to a stop codon (TAG), and th e mutation was d esignated E2858X. 
This mutation c reates a novel restrictio n site fo r the endonuclease 
BJal and was used to con~irm the mutation in the patient and 
materna l genomic DNA (Fig 4C). 
Idenlificatioll oj a Patema/ Missellse M llialioll: Heteroduplex ana lys is 
of the PC R products spanning exons 103/104 (Fig SA) revealed 
heteroduplex bands in the patient and patcrna l sampl es, but only a 
homoduplex in the mate rnal sampl e. Automated sequencing of the 
peR product (Fig SB) discloscd a G- to-A transition at nucleotide 
position 30157 in exon 103 . T his ch an ges a glyc ine res idue (!:,iGG) 
to an arginine (AGG), and the mutation was design ated G2576R. 
T lus mutation results in the loss of a restriction site for the 
endonuclease tvlsp I, and was used to confirm the mutation in the 
patient and paternal genomic DNA. Analysis of 100 clu'omosomes 
from unrelated individuals and 100 chro mosom es from patients 
with recess ive DEB by be te roduplex analysis and restriction endo-
nuclease digestio n did not reveal the presence of this missen se 
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Figure 2. Anti-type VII collagen iUlmunofluorescence microscopy 
findings using the LH7:2 antibody. n) Labeling in the patient's skin 
shows norm<11 or near-nom1al in tensiry ar the dermal-epidermal j unction. 
compared with the labeling pattern in normal human skin in Pa ll cl b. In 
addition. in the patient samplc, areas of earl)" blistcr fonnation arc prcscllt 
(lln ll ef n, ar/"O/IIs). In such sites. the anti-type Vl1 collagen antibody labeling 
is present on the roof of separated skin, indicating cleavage beneath the 
lamina densa. c) LH7:2 labeling in a pa tient with the severe, HaIIopeau-
Siemens fo rm of recessive DEU shows the complete absence of staining of 
the dermal-epidermal junction. Scale bnrs, 100 ILm) . 
mutation, suggesting that G2576.R is neithcr a common polymor-
phism , no r the basis of recessive DEB in the oth e r patients studied . 
D ISCUSS ION 
T he RDEB patient examined in this study is a comp o und h ete ro-
zygote for a no nsense mutation (E2858X) in exon 116 and a 
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Figure 3. E lectron n'icrographs of the recessive DEB patient skin. 
II) Low magnification revea ls tissue separation (lIs,cr;sk) below the level of 
the lalllina densa. Senle bllr, 10 {.L111. I) Higher magnification examination of 
in tact dermal-epidermal junction reveals sOllle di scernible anchoring fibril-
like structures (IIrro .lls) be'1l!ath the lam ina densa, in addition to some more 
ill-defined wisp-like structures (nr"""J /r cllds). Senir bllr. 1 {.L1ll. 
missense mutation (G2576R) in exon 103. T hese fmdings are of 
interest in view of the clinical phenotype of the patient, the positive 
anti - type Vll collagen immunofl uo rescent stai ning, and the ultra-
structura l observa tions ofabnorma.l anchoring fIbril m o rpho logy, in 
the context of the pattern of the type of COL7Al mutations 
underlying DEB r6]. 
THE JOU llNAL OF INVESTIGATIVE DERMATOLOGY 
In the most severe clinical subtype of recessive DEB (Hallopeau-
Siemens form) [1] , the COL7 Ai mutations in volve the creation of 
premature termination codons (PTCs) o n both all eles, either 
through nucleotide insertions or deletions or sin gle base pair 
substi tutions [20 - 23 ]. Although such mutations co uld potentially 
lead to the synthesis of trunca ted polypeptides, it appears that the 
main effect of any PTC, othe r than those in the last or penultimate 
exon , is to create an unstable mRNA transcript and, consequently, 
little if any fu n ctional protein fI'om the mu tant alle le [24,25]. The 
exon 116 mutation (E2858X) in o ur patient is a further example of 
a PTC in recessive DEB, although RNA sa mpl es were not available 
to study mRNA processin g in association with a PTC close to the 
3' end of the gene in thi s family. 
T he paternal mutation, a glycin e res idu e su bstituted by all 
arginin e codon , is of considerable interest in the context of tlle 
ch aracte ri stic G ly-X- Y repeating prim",'y structure of coll agens. 
T hi s mutation, G2576R, occurs w ithin a collagenous region oftypc 
VII collagen consisting of74 contiguo us G ly-X-Y repea t sequences 
[1 9]. G lycine substitutions on one all e le have been reported as tlle 
molecular basis for some cases of dominant DEB, with anchoring 
fIbril abnorm ali ties and tissue {i'agility resulting fI'om a do rninant-
negative effect between type VB collagen polypeptides synthesized 
from the normal and mutant all eles [6,26]. However, not all glycine 
substitu tions within the collagenous trip le helix appea r to have sllcb 
an effect, since several g lyci ne substit u tions appear to be "silent" 
when present in the heterozygous state with a normal COL7 A1 
all e le. I [n con trast, th e presence of sllch a g lycine substitution in the 
homozygous state may indeed g ive ri se to a clinica l phenotype. ~fe 
have previously reported this phenomenon in COL7Al in a 
recessive DEB patient with th e homozygous mutation G2570R 
[27), but its occurren ce h as also been noted in other collagen genes, 
specifi cally in COLll A2, giving rise to an autosom al recessive form 
of osteochondrodysp lasia [28]. 
Careful clinica l examinatio n of the patient's tather for evidence 
of active or previous skin fragility , including a search for subtle nail 
dystrophy, did not reveal that heterozygosity fo r the glycine 
substitution G2576R had any clinical seque lae, suppo rting the 
hyp oth esis that this g lycine subst ituti on is indeed "silen t" in the 
heterozygous st:rte in association with a second no rmal COL 7 Al 
all e le. Assessment of 100 chro m osom es fr01l1 unrelated, unaffected 
individuals by heterodupl ex analysis and restriction endonuclease 
digestion did not reveal the presence of G2576R, arguing against 
this missense 1I1u tation representi ng a com1l10n polymorphism. 
T he genotype-p henotype corre latio ns fo r COL7 Aland DEB 
fi'om this study, therefore, a re that a "sil ent" glyc ine substitu tion 011 
one allele, whcn combin ed w ith a PTC on tlle other allele. resul ts 
in a moderately seve re recessive DEB phe notypc , with genera lized 
• Zhan g X, Christiano AM . Uitto J: Ev idence for positional effects of 
glycine substitutions in th e trip le helical domain oftypc VII coHagen.) 1.IIJest 
O .. rrlllltol l04:5tl1 . 1995 (abst.) 
C CTCCQ,AGTA CTCCIAGTA 
Figure 4. Identification of a ttlaternal non-
sense mutation within COL7Al exon 116. A) 
Heteroduplex analysis reveals a shift in the patient 
and maternal PC R produ cts but not in till! paternal 
salllple or control DNA sa nlple (IIIIIC f). B) auto-
lI1ated sequencing reveals a G-to-T transversion at 
nucleotide position 338 10, that converts a glu-
tamic acid residue (gAG) to a premature stOP 
codon (IAG). T he Illutation is designated 
E2858X. q verification of the mutation by BJr.1 
restri ctio n endon uclease digestion . The patient 
and mate rnal PCR. product of 274 bp is partially 
cie:rved into digestion products 153 and 121 bp in 
size, indicating that the patient :rnd mother are 
heterozygous for the mutation E2858X. In con-
trast. the paternal and control s'"llple (11111 ,. q arc 
not cleaved, showing a single undiges ted PC R 
product 274 bp in size. 
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mucocutaneous fragi lity, but la cking the extensive scarring seen in 
the severe Hall opea u-Siemen s ph enotype, in w hi ch the gen etic 
basis ha s been estab lished as PTCs on both alleles [20 - 23]. T he 
findings in our study are helpful in d efi nin g some of the molecular 
pathology that may be present in DEB phenotypes of intermediate 
severity, particul arly those cases in w hich immunoAuorescence 
microscopy shows normal o r ncar-n o rmal anti-type VII co llagen 
antibody staining at the derm al-epidermal junction . 
Of more direct relevance to the fami ly in this case is the fa ct that 
understa nd ing the mo lecular ba sis of recessive DEB in this patient 
facili tates DNA-based prenata l diagnosis for subsequent pregnan-
cies b y first trimester cho ri onic vi llus biopsy [29,30J. T hi s consid-
eration is particu larl y rel evan t in this case. since altho ugh the 
clinical features in the patient are relatively severe, prenatal diag-
nosis through feta l skin biopsy 131 J has prev iously been avoided 
because of the iml11unoAuorescence microscopy fll1di ngs of bri ght. 
linear type V.II co ll agen labeling at the derma l-e pide rm al junction, 
indistinguishable fi'om 11 0 rmal control skin . T hu s, thro ugh DNA 
analysis, an accurate m eans of prenatal diagnosis is now ava il able 
for thi.s fami ly. In addition. the disclosure of the COL7 A I mutati o ns 
in this case also pe rmits prenatal diagnosis to be made at an even 
earli er stage by preimp lantation diagnosis thro ugh blastomere 
biopsy at the e ight-cell stage of e mbryoni c deve lopm ent [32 1. 
Finally, knowing the m o lecu lar basis of recess ive DEl3 in this fam ily 
provides the foundation for the design of gene therapy approaches 
in this patient. 
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